Author:
Galliera Emanuela,Tacchini Lorenza,Corsi Romanelli Massimiliano M.
Abstract
AbstractMatrix metalloproteinases (MMPs) play a pivotal role in remodeling the extracellular matrix (ECM) and are therefore of interest for new diagnostic tools for the clinical management of diseases involving ECM disruption. This setting ranges from the classical areas of MMP studies, such as vascular disease, cancer progression or bone disorders, to new emerging fields of application, such as neurodegenerative disease or sepsis. Increasing the knowledge about the role of MMPs in the pathogenesis of diseases where a clear diagnostic panel is still lacking could provide new insight and improve the identification and the clinical treatment of these human diseases. This review focuses on the latest descriptions of the clinical use of MMP as biomarkers in the diagnosis, prognosis and monitoring of different diseases, such as diabetes, cardiovascular diseases, cancer and metastasis, neurodegenerative disorders and sepsis.
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference72 articles.
1. metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease;Benjamin;Matrix EXS,2012
2. metalloproteinases protective roles in cancer;Decock;Matrix J Cell Mol Med,2011
3. metalloproteinases and their inhibitors in vascular remodeling and vascular disease;Raffetto;Matrix Biochem Pharmacol,2008
4. metalloproteinases in human spontaneous intracerebral hemorrhage an update;Florczak;Matrix Cerebrovasc Dis,2012
5. NA Extracellular matrix metabolism in diabetic nephropathy;Mason;J Am Soc Nephrol,2003
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献